Holders — by stockHoldings — by fund
BOONE CAPITAL MANAGEMENT LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001882053
$427.5M
disclosed book value
16
positions
11.5%
largest position share
Positions, as of 2026-06-30
top 16 of 16 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | TFXTELEFLEX INCORPORATED | 387,388 | $49.1M | 11.5% |
| 2 | MIRMMIRUM PHARMACEUTICALS INC | 415,641 | $48.7M | 11.4% |
| 3 | CITHE CIGNA GROUP | 159,290 | $43.9M | 10.3% |
| 4 | IONSIONIS PHARMACEUTICALS INC | 519,977 | $41.2M | 9.6% |
| 5 | UNHUNITEDHEALTH GROUP INC | 88,687 | $36.9M | 8.6% |
| 6 | BMRNBIOMARIN PHARMACEUTICAL INC | 583,219 | $33.4M | 7.8% |
| 7 | GRDNGUARDIAN PHARMACY SVCS INC | 711,939 | $29.8M | 7% |
| 8 | VSTSVESTIS CORPORATION | 1.9M | $27.6M | 6.5% |
| 9 | BBIOBRIDGEBIO PHARMA INC | 339,720 | $25.3M | 5.9% |
| 10 | PNTGPENNANT GROUP INC | 515,818 | $19.1M | 4.5% |
| 11 | GLUEMONTE ROSA THERAPEUTICS INC | 615,287 | $14.9M | 3.5% |
| 12 | KODKODIAK SCIENCES INC | 378,010 | $14.7M | 3.4% |
| 13 | TNGXTANGO THERAPEUTICS INC | 455,605 | $14.2M | 3.3% |
| 14 | KYMRKYMERA THERAPEUTICS INC | 113,173 | $13.0M | 3% |
| 15 | CGEMCULLINAN THERAPEUTICS INC | 704,442 | $12.8M | 3% |
| 16 | ANLADLAI NORTYE LTD | 258,390 | $3.0M | 0.7% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.